Reports without reliable country information are labeled as country not specified. PulseGLP analyzed 90 relevance-ranked patient reports across GLP-1, Semaglutide, Ozempic from r/GLP1, r/Semaglutide, r/Ozempic. The strongest structured pattern in this sample is symptom: Other, appearing in 24 extracted reports. The matching posts skew Neutral-Low, Risk-Alert, Positive. This is a matched-sample finding, not a population-wide prevalence estimate.
Share of structured matched reports; this is not a population prevalence estimate.
Patient reports vary widely; ask your prescriber before changing dose, stopping medication, or treating persistent symptoms.
"Devastated So I have been on Zepbound for a year and lost a significant amount of weight but about a month ago it needed a prior authorization and my medicaid denied it because it says im now in a regular BMI."
Patient · GLP-1 · r/GLP1 · United States
"CVS is adding Zepbound back to its formulary effective October 1 Huge news for those who lost coverage."
Patient · GLP-1 · r/GLP1 · United States
"This is because Reta isn’t yet FDA approved so most taking it aren’t obese nor are the studies out there yet. It doesn’t suggest Reta is different. Reta is more powerful so tends to have more effects."
Patient · Retatrutide · r/Retatrutide · United States
"This is because Reta isn’t yet FDA approved so most taking it aren’t obese nor are the studies out there yet. It doesn’t suggest Reta is different. Reta is more powerful so tends to have more effects."
Patient · Retatrutide · r/Retatrutide · United States
Sourced from GLP-1 patient communities · See community discussion →
Published: · Updated: